LY2624803

LY2624803 is a 5-HT2A and histamine, H1 receptor antagonist[1][2].

Product Specifications

CAS Number

[879409-35-5]

UNSPSC

12352005

Target

5-HT Receptor; Histamine Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/ly2624803.html

Solubility

10 mM in DMSO

Smiles

O=C(C(C)(CN1CCN(CC1)C2=NC3=C(OC4=C2C=CC=C4)C=CC=C3)C)O

Molecular Formula

C22H25N3O3

Molecular Weight

379.45

References & Citations

[1]Abad VC, et al. Insomnia in Elderly Patients: Recommendations for Pharmacological Management. Drugs Aging. 2018;35 (9) :791-817.|[2]Zisapel N. Current Phase II investigational therapies for insomnia. Expert Opin Investig Drugs. 2015;24 (3) :401-411.